Skip Navigation
Skip to contents
Filter

ARTICLE TYPE

PUBLICATION DATE

8 results
Display

Clinical pharmacologic aspects of immune checkpoint inhibitors in cancer therapy

Kim KP, Jung H

During the past two years, three immune checkpoint inhibitors, ipilimumab, nivolumab and pembrolizumab, have been approved and revolutionized cancer immunotherapy. Translational and clinical pharmacology of these agents have contributed in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
How a VOICE for clinical pharmacology turns into a RECIPE for its development

Aronson JK

Pharmacology is the study of the actions of synthetic or semisynthetic chemicals or naturally occurring substances on molecules, cells, tissues, and living organisms, as seen in physiological and pathological systems,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Brief introduction to current pharmacogenomics research tools

Cha EY, Jeong HE, Kim WY, Shin HJ, Kim HS, Shin JG

There is increasing interest in the application of personalized therapy to healthcare to increase the effectiveness of and reduce the adverse reactions to treatment. Pharmacogenomics is a core element in...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Mixed?effects analysis of increased rosuvastatin absorption by coadministered telmisartan

Park WS, Jang D, Han S, Yim DS

The Cmax and AUC of rosuvastatin increase when it is coadministered with telmisartan. The aim of this study was to explore which of the pharmacokinetic (PK) parameters of rosuvastatin are...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
HPLC-UV method for the simultaneous determinations of ascorbic acid and dehydroascorbic acid in human plasma

Kim Y, Kim MG

A high performance liquid chromatography (HPLC) paired with UV-vis detection method to determine ascorbic acid and its oxidation product, dehydroascorbic acid, in human plasma was developed. Ascorbic acid in human...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Development of a validated liquid chromatography-tandem mass spectrometry assay for the quantification of simvastatin acid, the active metabolite of simvastatin, in human plasma

Park HJ, Hwang AK, Kim AR, Kim SH, Kim EH, Cho SH, Ghim JL, Choe S, Jung JA, Jin SJ, Bae KS, Lim HS

Simvastatin is a lipid-lowering drug that is metabolized to its active metabolite simvastatin acid (SA). We developed and validated a sensitive liquid chromatography-tandem mass spectrometry (LC/MS/MS) method to quantitate SA...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Screening study for genetic polymorphisms affecting pharmacokinetics of simvastatin

Im S, Kim BH, Lee K, Kwack K, Yim SV

Simvastatin reduces plasma cholesterol by inhibiting HMG-CoA reductase (HMGR) and is widely used in the treatment of hypercholesterolemia. To screening the possible genetic factors affecting the pharmacokinetics (PK) of simvastatin,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Development and validation of a UPLC-MS/MS method for the quantification of acetaminophen in human plasma and its application to pharmacokinetic studies

Cha J, Kim BK, Gwon MR, Lee J, Ohk B, Kang WY, Lim MS, Seong SJ, Kim HJ, Lee HW, Yoon YR

We developed an ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method for the determination of acetaminophen concentration in human plasma. Following protein precipitated extraction, the analytes were separated and analyzed using...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr